MalinHultcrantzMDPhD

PubMed

• Unscheduled healthcare interactions in multiple myeloma patients receiving T cell redirection therapies.
  Anna J Howard, Isabel Concepcion, Alice X Wang, Issam S Hamadeh, Malin L Hultcrantz, Sham Mailankody, Carlyn Rose Tan, Neha Korde, Alexander M Lesokhin, Hani Hassoun, ...> ;Blood Advances. 2024 Apr 12
• Patterns of CRS with Teclistamab in Relapsed/Refractory Multiple Myeloma patients with Prior T-Cell Redirection Therapy.
  Issam S Hamadeh, Tala Shekarkhand, Colin Joseph Rueda, Ross S Firestone, Alice X Wang, Neha Korde, Malin L Hultcrantz, Alexander M Lesokhin, Sham Mailankody, Hani Hass...> ;Blood Advances. 2024 Apr 10
• Genomic Classification and Individualized Prognosis in Multiple Myeloma.
  Durante, M. A., Francesco Maura, Arjun Raj Rajanna, Bachisio Ziccheddu, Alexandra M Poos, Andriy Derkach, Kylee Maclachlan, Michael Durante, Benjamin Diamond, Marios P...> ;Journal of Clinical Oncology. 2024 Apr 10
• 1 citations
  CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma.
  Ross S Firestone, Devin McAvoy, Tala Shekarkhand, Edith Serrano, Issam Hamadeh, Alice Wang, Menglei Zhu, Wei Ge Qin, Dhwani Patel, Carlyn R Tan, Malin Hultcrantz, Sham...> ;Blood Advances. 2024 Apr 9
• Development of a Multivariable Model to Predict the Need for Bone Marrow Sampling in Persons With Monoclonal Gammopathy of Undetermined Significance : A Cohort Study N...
  Elias Eythorsson, Saemundur Rognvaldsson, Sigrun Thorsteinsdottir, Thorir Einarsson Long, Elin Ruth Reed, Gudrun Asta Sigurdardottir, Brynjar Vidarsson, Pall Torfi Onu...> ;Annals of Internal Medicine. 2024 Apr 1
• Comparison of Infectious Complications with BCMA-directed Therapies in Multiple Myeloma.
  Lesokhin, A., Nath, K., Shekarkhand, T., Nemirovsky, D., Derkach, A., Costa, B., Nishimura, N., Farzana, T., Rueda, C., Chung, D., Landau, H., Lahoud, O., Scordo, M., ...> ;Research Square. 2024 Feb 7
• Prior cancer and risk of monoclonal gammopathy of undetermined significance: a population-based study in Iceland and Sweden.
  Rögnvaldsson, S., Thorsteinsdóttir, S., Syriopoulou, E., Sverrisdottir, I., Turesson, I., Eythorsson, E., Oskarsson, J., Long, T., Vidarsson, B., Onundarson, P., Agnar...> ;Haematologica. 2024 Jan 11
• 3 citations
  Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groups.
  Urvi A Shah, Erin Moshier, Andriy Derkach, Yuanhui Huang, Sham Mailankody, Carlyn R Tan, Kylee Maclachlan, Malin Hultcrantz, Neha Korde, Hani Hassoun, Santiago Thibaud...> ;Blood Advances. 2024 Jan 9
• Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
  Kumar, S., Callander, N., Adekola, K., Anderson, L., Baljevic, M., Baz, R., Campagnaro, E., Castillo, J., Costello, C., D'Angelo, C., Derman, B., Devarakonda, S., Else...> ;Journal of the National Comprehensive Cancer Network. 2024 Jan 1
• 1 citations
  Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
  Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson Jr, Muhamed Baljevic, Rachid Baz, Erica Campagnaro, Jorge J Castillo, Caitlin Costello, Christoph...> ;Journal of the National Comprehensive Cancer Network. 2023 Dec 1
• 2 citations
  Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens.
  Francesco Maura, Eileen M Boyle, David Coffey, Kylee Maclachlan, Dylan Gagler, Benjamin Diamond, Hussein Ghamlouch, Patrick Blaney, Bachisio Ziccheddu, Anthony Cirrinc...> ;Nature Cancer. 2023 Dec 1
• 2 citations
  Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial.
  Ajay K Nooka, Adam D Cohen, Hans C Lee, Ashraf Badros, Attaya Suvannasankha, Natalie Callander, Al-Ola Abdallah, Suzanne Trudel, Ajai Chari, Edward N Libby, Maria Chau...> ;Cancer. 2023 Dec 1
• Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma.
  Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, Amanda Ciardiello, Benjamin Diamond, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi Shah, Kylee Maclachlan, D...> ;Blood Cancer Journal. 2023 Jul 25
• 2 citations
  Disease associations with monoclonal gammopathy of undetermined significance can only be evaluated using screened cohorts: results from the population-based iStopMM st...
  Aðalbjörg Ýr Sigurbergsdóttir, Sæmundur Rögnvaldsson, Sigrún Thorsteinsdóttir, Ingigerður Sverrisdóttir, Guðrún Ásta Sigurðardóttir, Brynjar Viðarsson, Páll Torfi Önun...> ;Haematologica. 2023 Dec 1
• Author Correction: Prevalence of smoldering multiple myeloma based on nationwide screening.
  Sigrún Thorsteinsdóttir, Gauti K Gíslason, Thor Aspelund, Sæmundur Rögnvaldsson, Jón Þórir Óskarsson, Guðrún Á Sigurðardóttir, Ásdís R Þórðardóttir, Brynjar Viðarsson,...> ;Nature Medicine. 2023 Dec 1
• Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance ...
  Sæmundur Rögnvaldsson, Thorvardur Jon Love, Sigrun Thorsteinsdottir, Elín Ruth Reed, Jón Þórir Óskarsson, Íris Pétursdóttir, Guðrún Ásta Sigurðardóttir, Brynjar Viðars...> ;Blood Cancer Journal. 2023 Mar 20
• 1 citations
  Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort ...
  Neha Korde, Elizabet Tavitian, Donna Mastey, Joseph Lengfellner, Gil Hevroni, Andrew Zarski, Meghan Salcedo, Sham Mailankody, Hani Hassoun, Eric L Smith, Malin Hultcra...> ;Eclinicalmedicine. 2023 Mar 1
• 1 citations
  Bortezomib, Lenalidomide and Dexamethasone (VRd) vs Carfilzomib, Lenalidomide and Dexamethasone (KRd) as Induction Therapy in Newly Diagnosed Multiple Myeloma.
  Carlyn Rose Tan, Andriy Derkach, David Nemirovsky, Amanda Ciardiello, Benjamin Diamond, Malin Hultcrantz, Hani Hassoun, Sham Mailankody, Urvi Shah, Kylee Maclachlan, D...> ;Research Square. 2023 Feb 24
• 11 citations
  Prevalence of smoldering multiple myeloma based on nationwide screening.
  Sigrún Thorsteinsdóttir, Gauti K Gíslason, Thor Aspelund, Sæmundur Rögnvaldsson, Jón Þórir Óskarsson, Guðrún Á Sigurðardóttir, Ásdís R Þórðardóttir, Brynjar Viðarsson,...> ;Nature Medicine. 2023 Feb 1
• 5 citations
  Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
  Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson Jr, Muhamed Baljevic, Erica Campagnaro, Jorge J Castillo, Caitlin Costello, Christopher D'Angelo,...> ;Journal of the National Comprehensive Cancer Network. 2023 Jan 1
• 1 citations
  Assessment of renal outcome following therapy in monoclonal immunoglobulin deposition disease: Emphasizing the need for a consensus approach.
  Matthew J Pianko, Timothy Tiutan, Andriy Derkach, Jessica Flynn, Steven P Salvatore, Insara Jaffer-Sathick, Adriana C Rossi, Oscar Lahoud, Malin Hultcrantz, Urvi A Sha...> ;American Journal of Hematology. 2023 Mar 1
• 7 citations
  Pregnancy and childbirth outcomes in women with myeloproliferative neoplasms-a nationwide population-based study of 342 pregnancies in Sweden.
  Anna Ravn Landtblom, Therese M-L Andersson, Anna L V Johansson, Sophia Brismar Wendel, Frida E Lundberg, Jan Samuelsson, Magnus Björkholm, Malin Hultcrantz> ;Leukemia. 2022 Oct 1
• 83 citations
  GPRC5D-Targeted CAR T Cells for Myeloma.
  Sham Mailankody, Sean M Devlin, Jonathan Landa, Karthik Nath, Claudia Diamonte, Elizabeth J Carstens, Douglas Russo, Romany Auclair, Lisa Fitzgerald, Briana Cadzin, Xi...> ;The New England Journal of Medicine. 2022 Sep 29
• 13 citations
  Sustained Minimal Residual Disease Negativity in Multiple Myeloma is Associated with Stool Butyrate and Healthier Plant-Based Diets.
  Urvi A Shah, Kylee H Maclachlan, Andriy Derkach, Meghan Salcedo, Kelly Barnett, Julia Caple, Jenna Blaslov, Linh Tran, Amanda Ciardiello, Miranda Burge, Tala Shekarkha...> ;Clinical Cancer Research. 2022 Dec 1
• 20 citations
  Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study.
  Thorir Einarsson Long, Olafur Skuli Indridason, Runolfur Palsson, Sæmundur Rognvaldsson, Thorvardur Jon Love, Sigrun Thorsteinsdottir, Ingigerdur Solveig Sverrisdottir...> ;Blood Cancer Journal. 2022 Sep 14
• Join now to see all